About GSK
GSK is a Healthcare company based in Laval (Canada) founded in 1993, and was acquired by GSK in April 2023. GSK is engaged in developing biopharmaceutical solutions globally. It operates on a Direct-to-Consumer (D2C) and Professional Services model. GSK offers products and services including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions. Its focus areas include Pharmaceuticals and Biopharmaceuticals. Its legal entity is GSK plc.
Company details
GSK, a focused biopharmaceutical company, is dedicated to uniting science, technology, and talent to address diseases. Operations are centered on four therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health, with a commitment to impact 2.5 billion people by the end of the decade. Efforts are made to ensure access through responsible pricing and partnerships, while sustainability and ethical standards are prioritized across all activities.
- Latest Funding Round$35M (USD), Post-IPO
Jan 2019
- InvestorsNew Leaf Venture Partners
& 8 more
- Acquired byGSK
(Apr 2023)
Products & Services of GSK
GSK offers a comprehensive portfolio of products and services, including Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.
Solutions for respiratory conditions are developed and provided.
Cancer treatments are researched and offered for patients.
HIV therapies are created to manage the condition.
Treatments for infectious diseases are developed and distributed.
Apps and channels of GSK
its YouTube channel ViiV Healthcare has 133 subscribers and 30 videos.
Videos from GSK
The most watched videos on GSK's YouTube channel, ViiV Healthcare (133 subscribers). Click a video to play it here.
More on ViiV Healthcare.
Funding Insights of GSK
- Total Rounds 4
- Last Round Post-IPO β $35M
- First Round $9.61M
(Dec 2017)
- Investors Count 8
All 4 funding rounds of GSK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $35M | Post-IPO | β | β | |
| Dec 2018 | $25.68M | Post-IPO | β | β | β |
| Jan 2018 | $400,000 | Post-IPO | β | β | |
| Dec 2017 | $9.61M | Post-IPO | β | β | β |
9 investors in total: 9 institutional.
Investors in GSK
GSK has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include New Leaf Venture Partners, Orbimed and GSK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
| amzak.com | ||||
Venture capital funding is provided by Samsara BioCapital in California. | samsaracap.com | Palo Alto, United States | ||
Apple Tree Partners is engaged in life sciences venture capital. | appletreepartners.com | |||
Provides investment advisory, wealth planning, and portfolio management for clients. | 1964 | firstmanhattan.com | New York, United States | |
Offers savings plans, investments, and financing for businesses and individuals. | 1983 | fondsftq.com | Montreal, Canada | |
Taro Pharmaceutical Industries is engaged in developing and distributing pharmaceuticals. | 1950 | taro.com | Haifa, Israel | |
Developer of pharmaceuticals and vaccines for various therapeutic areas | 1715 | gsk.com | Brentford, United Kingdom |
Investor details for GSK
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GSK
15 people are tracked at GSK (1 in leadership, 13 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Andreas Orfanos | COO | Leadership |
Francesco Bellini | Chairman | Board & advisors |
Youssef L. Bennani | Board Member | Board & advisors |
Franklin M. Berger | Board Member | Board & advisors |
Clarissa Desjardins | Board Member | Board & advisors |
Pierre Larochelle | Board Member | Board & advisors |
William Mezzanotte | Board Member | Board & advisors |
Joseph Rus | Board Member | Board & advisors |
Jacky Smith | Board Member | Board & advisors |
Alan Goldsobel | Board Member | Board & advisors |
James Hull | Board Member | Board & advisors |
Lorcan McGarvey | Board Member | Board & advisors |
Alyn Morice | Board Member | Board & advisors |
Mandel Sher | Board Member | Board & advisors |
Roussen Pascal | Senior Project Manager | Team |
Complete people profiles for GSK
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GSK
5 dated milestones of GSK across 30 years, from founding to its latest funding, stage changes and deals.
- Founded GSK is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $9.6M.
- Funding Latest funding round, Post-IPO, of $35.0M.
- Exit Acquired by GSK.
Web traffic of GSK
Websites that share an audience with GSK (bellushealth.com).
Websites whose visitors overlap most with GSK. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| itrlab.com | 100% | 3.4K | #6,482,934 | View details | |
hea.sagepub.com | hea.sagepub.com | 54% | β | ||
oculist.net | oculist.net | 54% | #2,386,577 | β | |
makronova.com | makronova.com | 54% | β | ||
mhealth.org | mhealth.org | 54% | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gsk
Complete news archive for GSK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GSK
GSK was founded in 1993 and raised its 1st funding round 24 years after it was founded.
GSK is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
GSK, a focused biopharmaceutical company, is dedicated to uniting science, technology, and talent to address diseases. Operations are centered on four therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Solutions are developed to improve global health, with a commitment to impact 2.5 billion people by the end of the decade. Efforts are made to ensure access through responsible pricing and partnerships, while sustainability and ethical standards are prioritized across all activities.
GSK offers Respiratory Treatments, Oncology Therapies, HIV Medications, and Infectious Disease Solutions.
GSK has 9 investors. Key investors include New Leaf Venture Partners, Orbimed, GSK, Taro Pharmaceutical Industries, and First Manhattan.
GSK operates through Gsk Plc.
Yes. GSK was acquired by GSK in April 2023.

